Profile
BIOC DHR-PB TMO DHR IQV A
Company Name Biocept, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap - $916.76B $234.95B $194.50B $45.86B $41.70B
Employees 0.05K 79.00K 122.00K 61.00K 88.00K 17.40K
CEO Mr. Darrell Taylor Esq. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
BIOC DHR-PB TMO DHR IQV A
Quant Rating Score 4 5 3 3 3 3
Quant Rating Buy Strong Buy Neutral Neutral Neutral Neutral
Trading
BIOC DHR-PB TMO DHR IQV A
Last Close $0.4349 $1261.26 $615.07 $269.31 $251.55 $142.92
High 52 $1.67 $1261.26 $621.77 $280.76 $259.1 $154.64
Low 52 $0.43 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High -73.96 % 0 % -1.08 % -4.08 % -2.91 % -7.58 %
Price vs. 52 Week Low 1.14 % 0 % 42.57 % 45.49 % 41.99 % 41.27 %
Total Return
BIOC DHR-PB TMO DHR IQV A
1 Month Return 0 % 0 % -1.08 % -4.08 % 1.28 % 0.04 %
3 Month Return 0 % 0 % 8.29 % 4.87 % 14.82 % 9.59 %
6 Month Return 0 % 0 % 6.72 % 5.25 % -0.36 % 2.78 %
9 Month Return 0 % 0 % 23.97 % 20.51 % 15.97 % 10.97 %
YTD Return 0 % 0 % 15.88 % 16.41 % 8.72 % 2.8 %
1 Year Return -50.8 % 0 % 10.38 % 1.4 % 12.13 % 17.23 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIOC DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.39 % 0.24 % 0.39 % - 0.65 %
Dividend Paid and Capex Coverage Ration (TTM) -41.73 % 3.16 % 4.82 % 3.04 % 3.98 % 2.79 %
Dividend Per Share (TTM) - 1.05 % 1.48 % 1.05 % - 0.93 %
Payout Ratio (TTM) - 17.87 % 8.92 % 18.46 % - 19.25 %
Growth
BIOC DHR-PB TMO DHR IQV A
Asset Growth -48.9 % 0.16 % 1.62 % 0.16 % 5.3 % 2.19 %
Gross Profit Growth -110.99 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth -57.78 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year -43.02 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year -97.24 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year -93.01 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -1227.65 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -1036.23 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share 84.12 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share 99.2 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share 99.92 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -1227.65 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -460.14 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 92.98 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 99.63 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 99.95 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth -890.92 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth -890.92 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -79.4 % 5.14 % 7.9 % 5.14 % 8.21 % 12.05 %
Share Holder 3 Year Equity Growth Per Share -90.36 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -96.3 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share 100.01 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - -1.19 % 16.73 % -1.19 % - 7.8 %
Dividend 3 Year Growth Per Share - 28 % 59.21 % 28 % - 25.46 %
Dividend 5 Year Growth Per Share - 80.2 % 104.77 % 80.2 % - 51.49 %
Dividend 10 Year Growth Per Share - 1389.16 % 125.8 % 1389.16 % - 97.03 %
Debt Growth -4.45 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -765.53 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
BIOC DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 209.55 % 58.45 % 41.29 % 59.41 % 29.7 % 54.86 %
Return on Assets TTM -132.96 % 5.33 % 6.32 % 5.35 % 5.39 % 12.85 %
Return on Equity TTM -761.5 % 8.42 % 13.45 % 8.04 % 22.79 % 23.4 %
Return on Capital Employed TTM -184.96 % 7.39 % 8.59 % 6.21 % 10.68 % 17.47 %
Net Income Per EBT TTM 99.89 % 83.98 % 90.7 % 99.88 % 94.99 % 91.75 %
EBT Per Ebit TTM 92.48 % 94.74 % 95.32 % 94.37 % 70.93 % 102.39 %
EBIT Per Revenue TTM 352.6 % 21.3 % 16.99 % 21.13 % 13.9 % 23.15 %
Cash Flow To Debt Ratio TTM -116.66 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Receivables Turnover TTM -11.28 7.76 4.49 6.4 4.61 5.3
Payables Turnover TTM 6.74 6.49 9.76 5.21 3.23 5.9
Inventory Turnover TTM 17.94 4.12 4.78 3.21 - 3
Fixed Asset Turnover TTM -70.18 % 463.28 % 456.22 % 367.49 % 1979.04 % 449.31 %
Asset Turnover TTM -40.82 % 31.45 % 42.99 % 26.87 % 57.58 % 59.09 %
Operating Cash Flow Per Share TTM -13.05 9.27 24.47 8.74 13.39 6.16
Free Cash Flow Per Share TTM -13.36 7.39 20.85 6.92 10.03 4.89
Cash Per Share TTM 639.92 % 937.04 % 2312.57 % 321.85 % 920.97 % 613.45 %
Operating Cash Flow Sales Ratio TTM 149.86 % 26.52 % 22.08 % 30.55 % 16.05 % 27.49 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.4 % 79.76 % 85.18 % 79.14 % 74.88 % 79.34 %
Cash Flow Coverage Ratios TTM -116.66 % 36.11 % 26.4 % 35.4 % 18.4 % 60.91 %
Price To Free Cash Flows Ratio TTM - 35.06 29.51 38.12 25.1 29.43
Price To Operating Cash Flows Ratio TTM -0.03 29.05 25.13 30.81 18.78 23.21
Price Cash Flow Ratio TTM -0.03 29.05 25.13 30.81 18.78 23.21
Income Statement (TTM)
BIOC DHR-PB TMO DHR IQV A
Revenue $0.03B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $-0B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio -9.99% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.03B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.03B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -56.78 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
BIOC DHR-PB TMO DHR IQV A
Long Term Debt $0.01B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $0.02B $31B $51.88B $31B $20.57B $4.92B
Total Equity $0.01B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0.01B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.03B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
BIOC DHR-PB TMO DHR IQV A
Net Income $-0.03B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-0.82B $-0.52B $-0.82B $0B $-0.27B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 142.92
ACRS Aclaris Therapeutics, Inc. 1.18
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 1.91
AWH Aspira Women's Health Inc. 1.03
BDSX Biodesix, Inc. 1.96
BIAF bioAffinity Technologies, Inc. 1.5
BIAFW bioAffinity Technologies, Inc. 1.19
BNGO Bionano Genomics, Inc. 0.49
BNR Burning Rock Biotech Limited 5.295
CDNA CareDx, Inc 30.73
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.885
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 197.75
CSTL Castle Biosciences, Inc. 29.67
DGX Quest Diagnostics Incorporated 156.97
DHR Danaher Corporation 269.31
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to BIOC
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.58
Unlock